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1. Introduction
Stem cells have been opening a promising future in clinical therapies because of their two
remarkable  features  known as  self-renewal  and multi-lineage differentiation.  These  cells
can be classified in terms of their origin (embryonic, prenatal and postnatal stem cells) as
well  as  the  differentiation  commitments  (pleuripotent,  multipotent  and  unipotent).
Postnatal stem cells, also known as the adult stem cells (ASCs), normally exist in almost
every adult  tissues,  including bone marrow, skin,  neural  tissues,  and dental  epithelium,
acting as supportive cells by their regeneration capacity. Among different stem cell types,
ASCs  seem  to  be  more  applicable  in  stem  cell-mediated  therapies  and  regenerative
medicine because these cells lack ethical concerns, and possesses less tumorgenic potency
than their embryonic counterparts.
Recently, human dental stem cells (DSCs), a subtype of ASCs, have drawn worldwide attention
for future therapies due to their both technical and practical superiorities. In addition to having
some mesenchymal stem cell (MSC) characteristics, including plastic adherent ability with
formation of colonies in vitro, and also immunoprivileged properties, DSCs are easily-
accessible cells with higher proliferation capacity than ordinary marrow-derived MSCs.
Currently, there are six types of stem/progenitor cells determined in dental-related tissues. 1)
dental pulp stem cell (DPSCs), 2) stem cells from human exfoliated deciduous teeth (SHED),
3) periodontal ligament stem cells (PDLSC), 4) stem cells from apical papilla (SCAP) of
developing tooth, 5) dental follicle stem/progenitor cells (DFPCs) and 6) gingiva stem cells
(GSCs). DPSCs, SHEDs and SCAPs are referred to as dental pulp-related stem cells, and
PDLSCs & DFPCs as periodontium-related stem cells [1, 5].
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This chapter focuses on different aspects of dental-derived adult stem cells, such as their
classification, biological characterization, initiating culture, cultivation systems, cryopreser‐
vation and potential applications in tissue engineering and regenerative medicine. The data
are organized as three main parts, including: 1) Dental-related stem cell biology: from the
classification to the characterization and differentiation potential 2) Dental-related stem cell
initiation culture, culture systems and cryopreservation 3) Dental-related stem cell- based
tissue regeneration.
2. Dental-related stem cell biology: From the classification to the
characterization & differentiation potential
According to the literature, there are several types of stem/progenitor cells existed in dental
tissue. In this section, each of these cells will be described in terms of their main characteristics.
2.1. Dental Pulp Stem Cells (DPSCs)
The presence of stem cells in dental pulp tissue primarily have been reported in 1985 by
Yamamura [3, 4, 6] (Figure 1). Later on, Caplan et al. have demonstrated that these cells
presented osteogenic and chondrogenic potential in vitro, and could also differentiate into
dentin, in vivo. In 2000, Gronthos et al. have isolated dental pulp stem cells from adult human
dental pulp, which had the ability to regenerate a dentin-pulp-like complex [7]. Interestingly,
some recent works have found the presence of stem cells in inflamed pulp with capacity to
form mineralized matrix both in vitro and in vivo. These findings make dental pulp as an
interesting tissue source of putative stem cells, even in diseased form.[8]
DPSCs are similar to MSCs in some ways: they are of fibroblastic morphology with selective
adherence to solid surfaces, having good proliferative potential and capacity to differentiate
in vitro, and the ability to repair tissues in vivo. It’s interesting to note that DPSCs could
differentiate into not only osteoblasts, chondrocytes & adipocytes, but also myocytes, neurons
and hepatocytes lineages in vitro [4]. DPSCs are characterized by their negative expression of
hematopoietic antigens (e.g., CD45, CD34, CD14), and positive expression of stromal-associ‐
ated markers (e.g., CD90, CD29, CD73, CD105, CD44) (Table 1). They also express multipotent
marker (STRO-1) and extracellular matrix proteins, such as collagen, vimentin, laminin, and
fibronectin. [9-11]. Interestingly, some of the pluripotent stem cell markers, such as Oct4,
Nanog, Sox2, Klf4, SSEA4 & c-Myc have been reported to express on DPSCs [12-14]. More
recently, it was demonstrated that core transcription factor of the reprogramming Oct4, Nanog,
Klf4 and c-Myc become significantly down-regulated following the DPSC differentiation [4].
Apart  from stemness markers,  DPSCs are also shown to express  bone markers,  such as
bone  sialoprotein,  osteocalcin,  alkaline  phosphates  (ALP),  and  type  I  collagen.  This
indicates  their  differentiation commitment  into bone tissue [15].  On the other  hand,  the
expression of dentin sialophosphoprotein (an odontoblast specific protein precursor) is not
present  in the cultures of  hDPSCs implied that  these cells  represent  an undifferentiated
pre-odontogenic phenotype [7, 16].
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From  immunological  perspective,  it  has  been  reported  that  DPSCs  displayed  more
immnosuppressive  activities  than  the  BM-MSCs.  This  was  obvious  in  inhibiting  T  cells
response in vitro [17].
Based on some investigations, there is a sub-type of DPSCs referred to as “immature dental
pulp stems cells” (IDPSCs), which have promising potential in future stem cell researches.
IDPSCs were firstly, isolated from pulp tissue of the human exfoliated deciduous as well as
permanent teeth [18]. These cells express both embryonic and MSC markers (see part 2.2). It
has been indicated that transferring of human IDPSCs (hDPSCs) into mouse blastocysts
resulted in formation of human/mouse chimera which was able to retain proliferation and
differentiation capacity [19]. Furthermore, hIDPSCs possess the capacity to rapidly reprog‐
rammed into induced pleuripotent stem cells (iPSc) which are able to produce primary
hIDPSC-iPSC colonies even under feeder-free conditions [20].
2.2. Dental Stem cells from Human Exfoliated Deciduous teeth (SHED)
In 2003, Miura et al. have reported to isolate a stem cell population from the living pulp
remnants of exfoliated deciduous teeth. These authors have termed the cells as stem cells from
human exfoliated deciduous teeth (SHED) [21] (Figure 1). These cells which are believed to be
of the neural crest origin are heterogeneous fibroblast-like population possessing an extensive
proliferating capacity than either DPSCs or BM-MSCs [22]. In terms of surface epitopes, it has
been found that they express markers of MSCs (STRO-1, CD146, SSEA4, CD90, CD73, CD 105,
CD106 and CD 166) and lack of hematopoietic/endothelial markers (CD34, CD31) (Table 1).
Under an appropriate culture conditions, SHED are able to differentiate into the variety of cell
types, including neural cells, angiogenic endothelial cells, adipocytes, osteoblasts, and
odontoblasts [23-25]. In vivo transplantation of SHED have been reported to result in formation
of bone and dentin like-tissue. [18, 21, 26-29]. There are some studies suggested that SHED is
different from IDPSCs in terms of expression of stem cell markers (see part 1.1)[18, 30].
Moreover, some research works have been reported that SHED would possess immunomo‐
dulatory function as seen in BM-MSCs [28].
2.3. Periodontal Ligament Stem Cells (PDLSC)
Periodontal ligament stem cells (PDLSCs) have first been introduced by Seo et al. [31] (Figure
1). Like MSCs, PDLSCs have been reported to form adherent clonogenic population of
fibroblast-like cells in the culture. They express both early MSC markers such as, STRO-1 and
CD146, and other MSC and pluripotent makers, such as CD44, CD90, CD105, CD73, CD26,
CD10, CD29 and CD166; meanwhile, they have no expression for CD40, CD80, and
CD86[31-33] (Table 1). Some investigations have revealed that PDLSCs may be positive for
embryonic stem cell markers, as well, including SSEA1, SSEA3, SSEA4, TRA-1-60, TRA-1-81,
Oct4, Nanog, Sox2 and Rex1, and ALP [34]. Based on some research works, SSEA4-positive
PDLSCs displayed the potential to generate adipocytes, osteoblasts, chondrocytes (from
mesodermal layer), neurons (from ectodermal layer), and hepatocytes (from endodermal
lineage) in vitro [31, 34, 35]. Furthermore, it has been shown that transplantation of PDLSCs
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into immunocompromised rodents resulted in the generation of cementum/PDL-like structure
and contributes to periodontal tissue repair [31].
PDLSCs show immunomodulatory activity by up-regulation of soluble immunosuppressive
factors (TGF-β1, hepatocyte growth factor (HGF) and indoleamine 2, 3-dioxygenase (IDO) in
the presence of activated peripheral blood mononuclear cells (PBMNCs). Similar to the DPSCs,
PDLSCs are positive for HLA-ABC (MHC class I antigen) while negative for HLA-DR (MHC
class II antigen) [32].
2.4. Dental Follicle Progenitor Cells (DFPCs)
In 2005 & 2007, Morsczeck et al. and Kémoun et al., respectively have identified unique
undifferentiated lineage committed cells possessing mesenchymal progenitor features in the
human dental follicle (Figure 1). The cells were referred to as “dental follicle precursor cells”
(DFPCs) [36, 37]. Characteristically, DFPCs, similar to the bone marrow stem cells, are adherent
and colony-forming cells. These cells have been reported to express Notch-1, CD13, CD44,
CD73, CD105, and STRO-1 [1, 36] (Table 1). Human DFPCs has been believed to consist of
precursor cells for cementoblasts, periodontal ligament cells, and osteoblasts. Under appro‐
priate in vitro conditions, they are capable of differentiating into osteoblasts, cementoblasts,
chondrocytes and adipocytes. Interestingly, although both DFPCs and SHED are of the neural
crest origin, their neural differentiation potentials are different under the same culture
conditions. It has been reported that SHED possess good differentiation potential than DFPCs
in terms of the expression of Pax6 which is a marker of retinal stem cells [27].
2.5. Stem Cells from the Apical Papilla (SCAP)
Stem cells from dental apical papilla (SCAP) were first identified and characterized by
Sonoyama et al. in human permanent immature teeth [38] (Figure 1). These authors described
the cells as adherent clonogenic cells with mesenchymal stem cell features, which are expressed
STRO-1, CD24, CD29, CD73, CD90, CD105, CD106, CD146, CD166, and ALP, and not express‐
ing CD34; CD45; CD18; and CD150. Among these markers, CD24 would be of a specific marker
for SCAP since it’s not found in the other dental stem cells (Figure 2). Excitingly, some authors
have reported that SCAP display higher telomerase expression than both DPSCs and BM-
MSCs [38]. Furthermore, SCAP has been shown to positively stain with several neural markers
implying their possible origin from the neural crest [39]. In terms of differentiation, SCAP are
capable of generating osteoblasts, odontoblasts and adipocytes in vitro. An in vivo study has
demonstrated that these cells form hard tissue when being loaded onto hydroxyapatite (HA)
and implanted subcutaneously in immunocompromised rats [38-40]. Moreover, SCAP have
been reported to possess a significantly higher mineralization potential as well as proliferation
rate than DPSCs. This finding might be of some importance for their use in dental and/or bone
tissue engineering and regeneration [41].
About the possibility of immunogenicity of SCAPs, an independent study have reported that
swine SCAPs are non-immunogenic and suppressed T cells proliferation in vitro [42].
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2.6. Stem Cells derived from Gingiva (GSCs)
The isolation of a stem cell population from gingiva was firstly reported by Zhang et al. in 2009
[43] (Figure 1). These authors derived the cells from the spinous layer of human gingiva and
referred to them as gingival stem cells (GSCs). In terms of markers, it has been shown that
GSCs are negative for CD45/CD34, but positive for CD29, CD44, CD73, CD90, CD105, CD146,
STRO-1 and SSEA4 (Table 1). In addition, extracellular matrix proteins, such as collagen,
vimentin, Collagen type-1, and fibronectin have been reported to express in these cells [43,
44]. Like MSCs, GSCs possess a differentiation potential into osteoblasts, adipocytes and
chondrocytes in vitro [45]. Moreover, these cells have been found to be able to differentiate
along endothelial as well as neural cell lineages. Furthermore, in vivo bone regeneration
potential of GSCs was demonstrated by transplantation of GSCs/HA into immunocompro‐
mised mice [45]. More importantly, in a comparative study, it was demonstrated that GSCs
showed stable phenotypes, maintain normal karyotype and telomerase activity in long-term
cultures in comparison with BM-MSC [45].
As with other dental related stem cells, GSCs has been found to display immunomodulatory
functions; they inhibit lymphocytes proliferation and express a wide range of immunosup‐
pressive factors, including Interleukin-10 (IL-10), IDO, inducible NO synthase (iNOS), and
cyclooxygenase 2 (COX-2) in response to the inflammatory cytokine, IFN- γ [43].
Figure 1. Timeline about the highlights in the history of the isolation of dental-related stem cells (see text).
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DPSCs SHED PDLSCs DFPCs SCAPs GSCs
CD (+) STRO-1 STRO-1 STRO-1 STRO-1 STRO-1 STRO-1
CD10 CD10 CD10
CD13 CD13 CD13 CD13 CD13 CD13
CD24
CD26
CD29 CD29 CD29 CD29 CD29 CD29
CD44 CD44 CD44 CD44 CD44 CD44
CD59 CD59 CD59
CD73 CD73 CD73 CD73 CD73 CD73
CD90 CD90 CD90 CD90 CD90 CD90
CD105 CD105 CD105 CD105 CD105 CD105
CD106 CD106 CD106 CD106 CD106
CD117
CD146 CD146 CD146 CD146
CD166 CD166 CD166 CD166




CD34 CD34 CD34 CD34 CD34 CD34
CD40




HLA-DR HLA-DR HLA-DR HLA-DR
Table 1. Cell Surface Marker Profiles of dental-related stem cells. DPSC; Dental pulp stem cell, SHED; Stem cells from
human exfoliated deciduous teeth, PDLSC; Periodontal ligament stem cells, DFPC, Dental follicle precursor cells, SCAP;
Stem cells from dental apical papilla, GSC; Gingival stem cells. [1-4]
3. Dental-related stem cell initiation culture, culture systems and
cryopreservation
In dental related stem cell researches, the first step is to isolate cells from tissue sources. The
next step is to expand the cells into sufficient number. In some occasion, it may be necessary
to preserve the cells for future use since tissue sources would not be available on demand. In
this section, we will describe the location of the certain teeth tissue from which the stem cell
population can be derived and followed by description of common methods by which the
isolation culture can be initiated. At the end, culture systems for the cell propagation as well
as the main points regarding issue of cell cryopreservation will be explained.
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3.1. Anatomical location of teeth tissue from which DSCs can be derived
Most of the human DSCs are come from teeth, which are subjected to the orthodontic treat‐
ments. Based on the studies, molars and premolars are mostly used for this purpose. Third
molars (wisdom teeth) are the most common teeth for extraction in dental clinical practice. In
addition, developing wisdom teeth during the adult life are the excellent candidates as the
accessible source of developing tissue similar to those in embryonic development. There are a
few studies considering the supernumerary teeth derived from other teeth, such as canine, for
the isolation of DPSCs [12] In some cases, such as the isolation of DPSCs from inflamed dental
pulps, endodontic treatments are used rather than orthodontics surgeries [46]. In any case,
considering the precise location of the dental tissues in tooth anatomy is important to achieve
certain types of DSCs with minimum cell contaminations. Hence, here is the brief description
of the localization for the specific DSCs isolation.
3.1.1. Tissues contained dental pulp-related stem cells (DPSCs, SHED & SCAP)
Isolation of DPSCs following the pulp extraction could be achieved by either through the root
or crown of the dental organ. In the case of SHEDs or DPSCs, which are derived from incom‐
pleted root teeth, the exposed pulp is accessible from the root without applying any specific
procedure [21]. In other situation (extracted permanent or deciduous teeth), dental pulp
extraction is accomplished through the dental crown by cutting the cementum-enamel junction
(CEJ) using dental instruments, such as pliers (bone forceps), extirpation needle, Gracey
curette, dental fissure burs, etc. [6] Moreover, in the case of inflamed teeth, pulp tissues are
removed during the endodontic therapies [46] (Figure 2)
The isolation of SCAP is achieved by gentle separation of root apical papilla from the surface
of the root with immature apex (i.e. located in the exterior of the root foramen area before the
complete eruption of tooth in the oral cavity) during the extraction of third molars [47]. Root
maturation results in the elimination of apical papilla; hence, the maturation period of teeth
are important for isolation of SCAP. (Figure 2)
3.1.2. Tissues contained periodontium-related stem cells (PDLSCs & DFPCs) & GSCs isolation
PDLSC can be obtained from the middle third of the root surfaces of extracted PDL tissue,
which is a soft connective tissue surrounded between the cementum and the inner wall of the
alveolar bone socket. It’s accomplished by scrapping surface of the middle third of the root [31].
DFPCs can be isolated by dissecting dental follicle from the upside of the dental  crown
from impacted teeth. Human dental follicle is an ectomesenchymal tissue that is derived
from cranial neural crest. This tissue surrounds developing tooth germ and involves in the
coordination of tooth eruption and periodontium formation. This tooth germ’s tissue can
easily be isolated after  wisdom tooth extraction by routine orthodontical  related surger‐
ies. Impacted teeth, usually third molars, normally fail to erupt through the gum because
of their encasement in the jawbone; therefore, routine surgical procedures are required for
the extraction. [36, 37]. (Figure 2)
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Figure 2. Overall view of dental-related stem cells based on different anatomical locations and stages during the hu‐
man lifetime in. a. tooth germ, b. primary teeth, c. permanent teeth.
GSCs could be isolated from clinically healthy gingiva, which are obtained as remnant or
discarded tissues following routine dental procedures [43]. (Figure 2)
3.2. DSCs culture initiation
In general, dental-related stem cells could isolate by either (1) enzymatic digestion (ED) of
tissues or (2) outgrowth (OG) from tissue explant. In the case of enzymatic digestion, after the
extraction, tissues are placed into the digestion enzymes, (generally, collagenase type-I &
dispase) for about 30-60 minutes at 37 °C to achieve single-cell suspensions. In order to purify
DSCs, single-cell suspensions could be subjected into (1) size-sieved isolation (using 3 µm
strainer followed by 20 µm strainer), (2) stem cell colony cultivation (single colony culture of
stem cells) or (3) magnetic/ fluorescence activated cell sorting (sorting based on surface
markers) [48].
In the outgrowth method (OG), tissues are minced into 1-2 mm pieces and placed into the
culture dishes to outgrowth [18]. More recently, Lizier and his co-workers established a scaled-
up hIDPSCs culture system based on in vitro re-plating of pulp tissue explants followed by
3-4 days expansion [49].
There are some evidences,  which suggested different behavior of DSCs according to the
ED or OG isolation methods [41, 50, 51]. According to Huang et al. DPSC isolated by ED
method  (DPSC-ED)  from  permanent  teeth  showed  higher  proliferation  rate  than  those
isolated  by  the  OG  method  (DPSC-OG)  [50].  Moreover,  STRO-1  &  CD34  markers  ex‐
pressed  more  in  DPSC-ED  in  comparison  with  DPSC-OG.  DPSC-ED  derived  from
deciduous and permanent teeth has been reported to display higher mineralization rate in
the defined osteo/odonto medium [51, 52].
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3.3. DSCs culture systems
Following the isolation of dental-related stem cells, the next step is to culture-expand the cells
into the multiple copies since in the most strategies related to the cell-based-treatment of tissue
defects, the copious amount of regenerating cells is needed. Many researchers have been
focused on optimizing effective conditions under which DSCs can efficiently be propagated.
On the other hand, differentiation potential of the multiplied cells must be determined because
discovering the potential commitments of the cells may lead to better selection of them for
future organ-targeted treatments [27, 48, 53]. Due to these considerations, this section opens
up a brief overview for different DSC culture systems designed for the cell expansion and
differentiation.
3.3.1. Serum free vs. serum rich culture systems
Normally, the isolation and expansion of DSC have depend on a high concentration of serum
culture media (10%), which provide better cell adhesion during the initial isolation of the cells.
Unfortunately, in long-term cultivation, the high level of serum might lead to spontaneous
differentiation or malignant transformation of cells. In addition, use of serum in culture may
result in contamination of cell culture with bovine pathogen for instance bovine spongiform
encephalopathy (BSE). For these reasons, serum free culture systems are highly recommended
[54-57]. In this regards, many attempt has been made to optimize DSC cultivation in serum-
free or low serum medium. For example, Karbanova et al. have reported that DPSCs cultivated
in low-serum medium exhibit less proliferation rate and different expression of stem cell
markers compared to those cultivated in serum rich medium [14]. In contrast, Hirata et al have
cultivated the cells in serum free media and have found the same survival rate of the cells as
those cultivated in the serum containing medium [58].
In the case of DFPCs, studies indicated that applying serum replacement media didn’t affect
the expression of connective tissue markers, such as collagen type I and type III, and also neural
stem progenitor marker, nestin [59]; however, there is no information about the possible
changes in other markers in this regards.
It’s interesting to note that SHEDs & PDLSCs cultivated in defined serum free media have
been reported to display higher proliferation rate than those cultivated in the medium
containing serum. Moreover such cells have found to express comparatively higher “stem‐
ness” markers [60]. Applying serum free media is one of the critical requirements for the future
clinical treatments; therefore, additional works are needed for optimizing conditions to achieve
final conclusion.
3.3.2. Neurosphere-forming vs. adherent culture systems
Sphere-forming culture systems are generally applied for neurogenic differentiation of stem
cells.  This  culture system has also been used for  DSC cultivation.  The idea of  applying
such a system came from the consideration of neural crest origin of DSCs. It has been well
established that neural stem/progenitor cells which are isolated from variety of sources are
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grown as  neurospheres  in  defined serum-free  culture  medium supplemented  with  EGF
and ⁄ or bFGF [61-63].
DSC Suspension culture was first suggested by Morita et al. (2007). These authors have
cultivated PDLSCs in the sphere culture and found that PDLSC have the ability to form
neurospheres in serum-free culture containing epidermal growth factor (EGF), basic fibroblast
growth factor (bFGF) and leukemia inhibitory factor (LIF) with the ability to differentiate into
both neural and mesodermal progeny [64].
In 2008, Sasaki et al. have cultivated DPSCs from the rat incisor in the sphere-culture and found
that under these conditions, the cells expressed neural and glial markers. They have also
noticed that CD81 positive DPSCs that were localized in odontoblast layer of apical portion of
the dental pulp may have more potential to form neurospheres [65] Later on, it was demon‐
strated that sphere form of SCAP had multi-differentiation potential into mineralized cells,
adipocytes and also myocytes under the defined media in vitro. Furthermore, In vivo studies
have indicated that sphere SCAP showed more potential to generate mineralized tissues in
comparison with the non-sphere SCAP [47].
3.3.3. Co-culture systems
Site-specific tissue interactions are essential for orchestration of proliferation, differentiation
and also homeostasis of cells during the tooth germ development. In particular, epithelial-
mesenchymal interactions are the most important developmental events, which are involved
in reciprocal crosstalk between the ectodermal and mesenchymal tissues. These sequential
interactions are critical for tooth morphogenesis and cell differentiation [66]. To imitate these
in vivo interactions, co-culture systems have been developed.
Using co-culture  systems,  some attempts  have been made to  promote  DSCs differentia‐
tion in vitro.  In this regards different cell  types have been examined as co-culture cells.
For  example,  it  has  been  demonstrated  that  co-culture  of  DFPCs/SCAP  could  lead  to
formation  of  bone-like  structure  in  vivo  and  in  vitro.  This  occurs  since  interaction  be‐
tween the cells stimulate cementogenic/osteogenic differentiation of DFPCs leading to up-
regulation of bone intermediate proteins, such as bone morphogenetic protein 2 (BMP2),
osteoprotegerin (OPG), bone sialoprotein (BSP) and osteocalcin (OCN), as well as down-
regulation  of  receptor  activator  of  nuclear  factor  κB  ligand  (RANKL)  [67].  In  other
experiment, Arakaki et al. have co-cultured DPSCs with dental epithelial cells and found
that  in  such  a  system,  dental  epithelial  cells  secret  BMP2  and  BMP4,  thereby  promote
odontoblastic differentiation of DPSCs [68]. Interestingly, it has also been reported that co-
culture  of  DPSCs  with  epithelial  cells  lead  to  epithelium  invagination,  as  well  [69].
Moreover,  Wang  et  al.  have  established  a  co-culture  of  hDPSCs  with  osteoblasts  and
demonstrated that a higher mineralization and up-regulation of osteogenic-related genes
in hDPSCs compared with those cultured in the absence of osteoblasts [70]. Furthermore,
co-culture  of  DPSCs  with  non-dental  MSCs,  such  as  amniotic  fluid-derived  MSCs  (AF-
MSCs), has been reported to leads to the bone differentiation of AF-MSCs indicating the
pre-commitment of DPSCs to induce osteogenic differentiation [71].
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3.4. DSCs cryopreservation
According to the diversity of dental-related stem cells and their remarkable features for cell-
mediated therapies and tissue engineering, developing a reliable method for cell banking have
become a priority for future use. In this regard, cryopreservation could be established at the
levels of teeth (organs), dental tissues or cells. In the case of teeth or dental tissues cryopre‐
servation, minimal processing may needed for banking. There are some evidences which are
demonstrated the successful cryopreservation of healthy and diseased teeth as well as dental
tissues [72-78]. On the other hand, cryopreservation of DSCs still has been considered as an
active area of the researches. There are several parameters which need to be considered prior
to an establishment of a successful and more efficient protocol. The parameters which need to
be determined include (1) DSCs-cultured passage(s), which leads to high-efficiency recovery
post thaw, (2) concentration of cryoprotective agent, (3) cell concentration for high-efficient
cryopreservation, (4) storage temperature, (5) the process of cryopreservation, and (6) evalu‐
ation of growth, surface markers and differentiation properties of DSCs after post thaw. So far,
there have been many researches considering the comparative cryopreservation methods for
optimizing the best protocols. More recently, it has been suggested that magnetic cryopreser‐
vation of DSCs was much better than conventional slow-freezing procedure in terms of
cytotoxicity [76, 79, 80].
4. Dental-related stem cell based tissue regeneration
Although DSCs are newborn in the field of stem cell therapy and tissue engineering, they have
opened the promising windows not only in tooth repair and regeneration studies but also in
other organs. To date, most of DSCs mediated cell therapies and tissue-engineering studies
have been focused on the animal models. However, more recently, a few clinical trial studies
have also been accomplished. Meanwhile, the immunogenicity of these cells should be more
considered for their allogeneic transplantation.
4.1. DSCs-based tooth engineering and regeneration of dental related tissue
In general, in the field of dentistry, the final goal of tissue engineering is to develop tooth-
replacement therapies using the whole-bioengineered-tooth technology. To fulfill this, some
authors have conducted the remarkable investigations. In this regard, there is some experiment
in which either dissociated tooth germs or mesenchymal and epithelial cells derived from the
tooth germs were prepared and loaded on to the prefabricated tooth-shaped scaffolds in order
to fabricate a bioengineered tooth. Based on these investigations, tooth germ cells possessed a
high potential to form dentin, enamel, pulp, and periodontal tissues in vivo [81-84]. However,
using embryonic tooth germ and problems related to immunogenicity of animal transplanta‐
tion, make this an unfeasible approach to clinical application of tooth regeneration [84].
Alternative cells  would be DSCs.  Using these cells,  some preliminary studies have been
accomplished to examine whether DSCs in combination with appropriate scaffold are able
to promote regeneration of tooth tissues [85, 86]. For instance, transplantation of PDLSCs
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loaded onto HA/TCP have been shown to result in the production of cementum in mice
while using gelfoam (collagen based gelatin sponge) as the carrier has been reported to
fail creating cementum [31, 87]. Sonoyama and co-workers have reported the creation of a
root/periodontal  complex  being  capable  of  supporting  a  porcelain  crown  in  swine  by
applying both SCAP and PDLSCs in HA/TCP as a carrier [38]. In a study on canine model,
we have recently succeeded to achieve regeneration on an experimentally-created defect in
peridontium  using  autologous  DPSCs  loaded  onto  Bio-Oss  scaffolds  [88].  Furthermore,
Nakashima et  al.  have reported a  successful  induction of  whole-pulp regeneration after
pulpectomy in a dog model using autologous DPSCs loaded onto 3D scaffold of collagen-
I & II and SDF-1 (stromal-cell-derived factor-1) as the morphogene [89, 90].  Moreover, a
culture  system  termed  as  organ-engineering  methods  using  PDLSCs  have  been  devel‐
oped  to  generate  not  only  tooth  root,  but  also  the  surrounding  periodontal  tissues,
including  PDL  and  alveolar  bone  in  mouse  model  [84].  In  addition  to  the  above-men‐
tioned animal  studies,  there  is  a  published retrospective  pilot  study in  human.  Accord‐
ing to  this  trial,  autologous transplantation of  PDL stem/progenitor  cells  might  provide
therapeutic  improvement for the periodontal  defects  without any adverse effects  during
32–72 months of follow-up [91].
4.2. DSCs-based tissue engineering and regeneration for other organs
Apart from the potential applications in dental tissue engineering and therapy, DSCs have
been opened a dynamic field in repair and regeneration of non-dental tissues. In this context,
there are many investigations indicating applicability of dental related stem cells in variety of
disease models in the animal. For instance, SHED has been reported to exhibit a potential to
improve parkinson’s disease in rat by differentiating into dopaminergic neuron-like cells.
Based on the different investigations, these cells have also the ability to promote wound healing
in mice [92-94]. It has been demonstrated that SHED also contribute to repair of the critical-
sized calvarial defects in mice model [95].
Transplantation of DPSCs has been shown to improve alzheimer’s and parkinson’s disease as
well as acute myocardial infarction in a rat model [96-98]. Similarly, transplantation of
hIDPSCs in canine model with golden retriever muscular dystrophy (GRMD) resulted in some
improvement [99]. In addition, it has been reported that transplantation of tissue-engineered
hIDPSC sheet was successfully reconstructed the corneal epithelium in rabbits with total limbal
stem cell deficiency (LSCD) [100]. Applying PDLSCs with collagen based gelatin sponge carrier
have been found to improve facial wrinkles by generating large amounts of collagen fibers in
the mouse indicating the potential capacity of PDLSC in the field of plastic surgery. In the case
of GSCs, Intra-peritoneal (ip) administration of the cells displayed improvement of inflamma‐
tion-related tissue destruction in experimental colitis [43].
4.3. Immunogenicity of allogeneic transplantation of DSCs
According to the promising place of DSCs in clinical treatments in future, considering the
immunogenicity of DSC transplantation is critical. Although autologous DSCs rather than
allogenous ones are preferred for repair and regeneration purposes, several limitations such
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as inadequate cell numbers and donor site morbidity carry out problems. Thus, more studies
will be needed to evaluate immunogenicity of allogenous DSCs for the future clinical appli‐
cations. There are some evidences suggested that DSCs, as the mesenchymal stem cells, have
immunomodulatory properties both in vitro and in vivo. These studies are almost considering
in vitro immunogenicity of DSCs by evaluating the expression of pro/anti-inflammatory
mediators, such as MHC classes, TGF-β, ODO, HGF, nitric oxide (NO), prostaglandin,
immunosuppressive minor H antigen (HLA-G), and interferon (IFN)-γ as well as effect of
DSCs in suppression of T cells proliferation [28, 101, 102].
In addition, in vivo studies also showed DSCs immunomodulatory functions. For instance,
SHED transplantation up-regulated the ratio of Treg (regulatory T cells) and Th17 in MRL/ lpr
mice model compared to the BM-MSCs; meanwhile, no change in the expression of IL-6 &
IL-10 was detected. On the other hand, transplantation of human DPSCs into the rat model
didn’t initiate the immunologic responses in recipients [103]. Moreover, in another study, it
was demonstrated that transplantation of hIDPSCs didn’t show the immune reaction in the
canine [99].
In spite of existing evidences, which suggested the immunomodulatory effect of DSCs, there
are some data proposing that there is different expression of immune receptors, such as toll-
like receptors (TLRs) on the cells. Presence of this receptor could affect the immumomodula‐
tory phenotypes of DPSCs and DFPCs [101, 104, 105]; On the other hand, since some studies
suggested that BM-MSCs may regain immunogenic property upon differentiation [106], the
subject of immunogenicity of DSCs must be examined not only in an undifferentiated state
but also in differentiated form.
5. Conclusion
Dental-related tissue contained several types of stem cells collectively referred to as dental
stem cells (DSCs). In this stem cell family, there are 6 named member so far recognized
and  described.  These  include  dental  pulp  stem  cell  (DPSCs),  stem  cells  from  human
exfoliated deciduous teeth (SHED),  periodontal  ligament stem cells (PDLSCs),  stem cells
from  apical  papilla  (SCAP)  of  developing  tooth,  dental  follicle  stem/progenitor  cells
(DFPCs) and gingival stem cells (GSCs). All these easily-accessible stem cells can be derived
from dental tissue obtained from both young and adult patients. Furthermore the cells are
described  as  having  immunomodulatory  function.  These  characteristics  make  DSCs  a
unique source for repair and regeneration of injured tissue. In this context, many studies
have so far been conducted on the animal models and the reports together indicated the
extensive potential of the cells in tissue repair and regeneration not only in teeth but also
in other organs. After all these animal studies, some centers have started clinical trials to
examine  the  cell  potential  in  human  diseases.  To  exploit  the  extensive  regenerating
potential of DSCs in clinic, many additional clinical trials must be planed and conducted
till therapeutic protocols using these cells become established.
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